For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20251224:nRSX7346Ma&default-theme=true
RNS Number : 7346M Fevara PLC 24 December 2025
24 December 2025
Fevara plc
("Fevara" or the "Group")
Completion of acquisition of Domino Industria E Comercio LTDA
Fevara plc (LSE: FVA), an international specialist in livestock supplements,
is pleased to announce that further to its announcement on 3 December 2025 it
has completed the acquisition of Domino Industria E Comercio LTDA, trading as
Macal ('Macal'), based in Campo Grande, Brazil.
For further information, please contact:
Enquiries
Fevara plc +44 (0) 1228 554 600
Joshua Hoopes, Chief Executive Officer
Gavin Manson, Chief Financial Officer
Hudson Sandler +44 (0) 20 7796 4133
Hattie Dreyfus / Nick Moore
About Fevara plc:
Fevara is an international specialist in livestock supplements.
Fevara's purpose is to empower farmers in extensive grazing systems with
research-proven products that boost profitability, improve resource efficiency
and support sustainable agriculture. The Group develops, manufactures and
markets research-proven supplements, including feed licks, blocks, bagged
minerals, and boluses for cattle, sheep and horses, sold under recognised and
trusted brands, including Crystalyx®, Horslic®, Horslyx®, Scotmin
Nutrition®, SmartLic® and Tracesure® Advanced.
Headquartered in Carlisle, Cumbria, in the UK, Fevara has five manufacturing
sites in the UK, US and Brazil, with three operational joint ventures in
Germany and the US. It serves customers in more than 20 countries through its
expansive international distribution and support network.
Fevara has been listed on the London Stock Exchange since 1972.
For more information, visit: www.fevara.com (http://www.fevara.com)
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
or visit
www.rns.com (http://www.rns.com/)
.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
. END ACQFXLLLELLXFBB
Copyright 2019 Regulatory News Service, all rights reserved